Do markers of bone turnover predict clinical outcome in patients with bone metastases?

被引：0
|
作者：
Guise, TA [1 ]
机构：
[1] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22908 USA
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2006年 / 2卷 / 05期
关键词：
bisphosphonate; bone metastases; bone-specific alkaline phosphatase; N-telopeptide of type I collagen; solid tumor;
D O I：
10.1038/ncpendmet0171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 259
页数：2
相关论文
共 50 条
  • [1] Bone turnover markers and bone metastases
    Seibel, M. J.
    OSTEOLOGIE, 2009, 18 (01) : 24 - 34
  • [2] Markers of bone turnover for the management of patients with bone metastases from prostate cancer
    P Garnero
    N Buchs
    J Zekri
    R Rizzoli
    R E Coleman
    P D Delmas
    British Journal of Cancer, 2000, 82 : 858 - 864
  • [3] Markers of bone turnover for the management of patients with bone metastases from prostate cancer
    Garnero, P
    Buchs, N
    Zekri, J
    Rizzoli, R
    Coleman, RE
    Delmas, PD
    BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 858 - 864
  • [4] Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases
    Zafeirakis, Athanasios G.
    Papatheodorou, Georgios A.
    Limouris, Georgios S.
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 249 - 253
  • [5] Biochemical markers of bone turnover in breast cancer patients with bone metastases: A preliminary report
    Shimozuma, K
    Sonoo, H
    Fukunaga, M
    Ichihara, K
    Aoyama, T
    Tanaka, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (01) : 16 - 22
  • [6] Bone turnover markers and novel biomarkers in lung cancer bone metastases
    Lang, Jiangli
    Zhao, Qian
    He, Yuedong
    Yu, Xijie
    BIOMARKERS, 2018, 23 (06) : 518 - 526
  • [7] Clinical use of markers of bone turnover in metastatic bone disease
    Seibel, MJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (10): : 504 - 517
  • [8] Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid
    Pectasides, D
    Nikolaou, M
    Farmakis, D
    Kanakis, I
    Gaglia, A
    Kountourakis, P
    Karamanos, NK
    Economopoulos, T
    Raptis, SA
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1457 - 1463
  • [9] Serum bone turnover markers in patients with primary bone tumors
    Wang, Jingsheng
    Pei, Fuxing
    Tu, Chongqi
    Zhang, Huaixian
    Qiu, Xueyong
    ONCOLOGY, 2007, 72 (5-6) : 338 - 342
  • [10] Expressiveness of Bone Markers in Breast Cancer with Bone Metastases
    Zulauf, Nicole
    Brueggmann, Doerthe
    Groneberg, David
    Oremek, Gerhard Maximilian
    ONCOLOGY, 2019, 97 (04) : 236 - 244
12345